ArticleCancer immunology, immunotherapy : CII2022

Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.

Hana Triki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.